A recent study reveals that people who discontinue new weight-loss injections like semaglutide or tirzepatide can put back on lost weight much more quickly than those who halt conventional lifestyle regimens.
Research printed in a prominent health publication demonstrates that while obese individuals can lose a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"People buying these drugs need to be informed of the potential of quick rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight within about 18 months.
Comparing Therapies
The research, which examined dozens of studies involving thousands of patients, contrasted the results of these new drugs with older methods.
Scientists emphasize that people who lose weight through diet and exercise generally experience a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Nutrition scientists suggest the mechanism of the injections explains the heightened weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Condition?
Medical guidelines suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians say that, given the significant potential of weight regain, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," comparing it to managing diseases like hypertension.
Patient Accounts
Individuals who have discontinued the medication describe a powerful resurgence of appetite.
"It felt as if a trigger activating and you're instantly ravenous," recalled one woman.
This challenge is worsened if individuals have not established sustainable lifestyle or habit modifications during treatment.
Growing Interest
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Adoption is higher among women than males.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, experts stress that while the jabs are potent tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on combined behavioural changes.
